POLICY: Entering University of Mississippi
Medical Center (UMMC) students are required to provide documentation of
immunization requirements included in this policy. For the purposes of this
policy, UMMC students are defined as individuals enrolled with UMMC schools and
students enrolled with the University of Mississippi’s School of Pharmacy.
Excluded from this definition are students in the following distance education
programs with no clinical or research components requiring the physical
presence of students on any UMMC campus: School of Dentistry – Advanced
Standing Dental Hygiene; School of Graduate Studies in the Health Sciences –
Biochemistry Certificate; School of Health Related Professions – Advanced
Standing Bachelor of Science in Medical Laboratory Science MLT-MLS, Advanced
Standing Bachelor of Science in Radiologic Sciences, Bachelor of Science in
Health Sciences, Bachelor of Science in Health Systems Administration,
Post-Baccalaureate Certificate in Health Informatics, Post-Baccalaureate Certificate
in Leadership and Management; John D. Bower School of Population Health –
Executive Master of Science in Population Health Management, Master of Science
in Population Health Science, Post-Baccalaureate
Certificate in Analytics, Post-Baccalaureate Certificate in Population Health
1. Measles, mumps and Rubella (MMR): Documentation of 2 doses of
live MMR vaccine for persons born in 1957 or later is required. The doses must
have been administered at least 28 days apart and at or after 12 months of age.
Laboratory evidence of immunity to measles, mumps and rubella OR laboratory
confirmation of disease is acceptable. Individuals born before 1957 must
provide laboratory evidence of disease or immunity to measles, mumps and
rubella, otherwise, 2 doses of MMR will be required.
2. Varicella vaccination: Two- dose Varicella vaccination series
given at least 30 days apart OR proof of immunity through laboratory evidence
of immunity (positive blood titer) or laboratory confirmation of disease for
students who have had a previous varicella infection. Verification of a history
of herpes zoster infection from a healthcare provider is also acceptable.
3. Tetanus/Diphtheria/Pertussis (Tdap) vaccine: All students
should submit proof of vaccination with 1 dose of Tdap received as an
adolescent or adult. If the Tdap vaccination date is more than 10 years, a
booster dose of tetanus /diphtheria toxoid (Td) is required. Tdap may be
administered regardless of the interval since the last dose of Td. Pregnant
students should receive Tdap during each pregnancy.
4. Mandatory annual influenza vaccine administration or a UMMC
approved contraindication or exemption must be documented during flu season,
between October 1st-March 31st.
5. Meningococcal vaccine: Students with
anatomic or functional asplenia or persistent complement component
deficiencies, should receive both MenACWY and MenB (Bexsero or Trumenba)
vaccine series. Students with routine exposure to N.
meningitides isolates or Students with anatomic or functional asplenia or
persistent complement component deficiencies should receive both MenACWY and
MenB (Bexsero or Trumenba) vaccine series. A 2-dose primary series of MenACWY
is required. A booster dose is required every 5 years. A 2-dose or 3 –dose
primary series of Men B is required. A booster dose is required every 2-3
years. This is optional for other students.
6. Hepatitis B vaccine: Proof of completion
of a 2-dose (Heplisav-B) or a 3-dose (Engerix-B or Recombivax HB) hepatitis B
vaccine series is required prior to school entry. Students are also required to
submit, prior to school entry, the results of a hepatitis B surface antibody
test. The submitted hepatitis B surface antibody results can be either positive
or negative but must be dated at least 30 days following completion of the
hepatitis B vaccine series.
A positive hepatitis B surface antibody titer
without documentation of appropriate doses of hepatitis vaccination is insufficient
in the absence of a history of resolved hepatitis B infection. If a student has
a positive hepatitis B surface antibody AND can provide clinical or laboratory
documentation of prior, resolved hepatitis B infection, this combination will
be acceptable documentation of immunity. Such students should contact Student
and Employee Health for guidance about what documentation of prior infection is
7. Tuberculosis screening: A two-step TB Skin test or a TB blood
(IGRA) test is required for baseline TB screening of all students. The approved
IGRA tests are QuantiFERON-TB Gold and T-Spot tests. Students who choose to
screen using a TB skin test must submit documentation of a two-step TB skin
test performed within 90 days (3 months) prior to school entry. The second dose
of the two-step TB test must be placed within 28 days of the initial TB skin
test. If the TB skin or the IGRA test is positive, a chest x-ray report must
also be submitted. Students residing in the United States who have been undergoing
annual TB skin test screening prior to enrollment may submit two or more
consecutive annual reports of negative TB skin tests, one of which must have
been done within three months of school enrollment, in lieu of the two-step TB
skin test. Students with a previously positive TB skin test or students with a
history of immunization with BCG should submit an IGRA test report obtained
three months prior to school entry. Students who have been treated for Latent
TB infection in the past are required to complete a pulmonary history form and
submit a copy of the treatment record and chest X-ray report. International
students are required to submit an IGRA test and chest X-ray reports, both
performed in the United States within 45 days of school enrollment. Additional
details regarding annual TB testing can be found in the UMMC policy on Student
TB Screening (https://documents.umc.edu/ViewPolicy.aspx?pid=E-AA-GEN-GEN-PO-00016 ).
Students will provide proof of TB testing within three (3) months
prior to the date of school entry. Date of school entry for Pharmacy students
is considered to be the start of the P1 year. TB screening for Pharmacy
students is managed according to the University of Mississippi School of
Individuals for whom testing is
medically contraindicated will provide sufficient evidence from a qualified
medical provider to document their TB status. Cases in which applicants test
positive for TB or who have special circumstances regarding their TB status
will be reviewed by the medical director of Student Employee Health. Further
evaluation may be required.
Questions regarding levels of immunity and other interpretation
of testing results are resolved by Student and Employee Health.
UMMC reserves the right to revoke acceptance of students and to
deny admission to any of its programs as it determines appropriate based on TB
status, required vaccination status, and the best interests of the Medical
Record of vaccination should be documented on the Mississippi
Certificate of Immunization Compliance, Form 121 or the University of
Mississippi Medical Center Immunization record form. This form must be
completed by a licensed healthcare provider: a physician, a licensed Nurse
Practitioner, a licensed nurse, physician assistant, pharmacist, or a public
SCOPE: All schools
Immunization of Health-Care Personnel: Recommendations of ACIP.
MMWR 2011; 60 (RR07):1-45. http://www.immunize.org/catg.d/p2017.pdf
Mandatory Influenza Vaccination Policy. UMMC
Policy A-SEH-GEN-GEN-PO-00001: University of Mississippi Medical Center. Available from https://documents.umc.edu/policy/A-SEH-GEN-GEN-PO-00001/